Skip to content
Research Article Open access CC BY 4.0

Review on Transferosomes and Transferosomal Gels

P. Kranthi Kumar, R. Santosh Kumar

Journal of Pharmaceutical Research International · pp. 114–126 · Published 9 Sep 2021

10.9734/jpri/2021/v33i43B32532

Abstract

Transdermal drug delivery systems (TDDS), which are self-administrable and non-invasive, can improve bioavailability and patient compliance by bypassing first-pass metabolism. Vesicular-based TDDS have attracted a lot of attention in recent years because they're designed for controlled, efficient, and targeted drug delivery. One of these delivery technologies, transferosomal-based formulations, has grown in popularity due to its ability to achieve all of the desired criteria and quality qualities. Transferosomes combine the characteristics of liposomes and niosomes because they contain both liposomes (phospholipids and cholesterols) and niosomes as components (nonionic surfactants; edge activators). as a result, they are referred to as the first generation of elastic liposomes. However transdermal drug delivery is difficult due to the presence of the skin's protective barrier, transferosomal drug delivery overcomes all obstacles due to its unique characteristics, such as its ultradeformable vesicular nature. The benefits, limitations, modes of penetration, formulations, production and assessment methodologies, and pharmaceutical uses of transferosomal drug delivery systems are discussed in this paper. Conclusion: Transferosomes have several importance over other vesicular systems, including greater deformability, greater penetration power across skin, the ability to deliver systemic drugs, and higher stability.

Transferosomes transdermal phospholipids penetration bioavailability Gel

Cited by 16

Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications

Bhupendra Dixena, Rashmi Madhariya, Anupama Panday · Current Drug Delivery · 2025

Potential role of resveratrol and its nano-formulation as anti-cancer agent

Akshay Kumar, Balak Das Kurmi, Amrinder Singh · Exploration of Targeted Anti-tumor Therapy · 2022

RETRACTED: Rational design and translational advancement of phospholipid-based nanocarriers for targeted cancer therapy

Kateryna Mykhailivna Doroshenko, Oleksander Ivanovich Shefchenko · Bioorganic & Medicinal Chemistry Letters · 2025

From Liposomes to Virosomes: Evolution of Phospholipid Nanocarriers in Drug Delivery

Kateryna Mykhailivna Doroshenko, Oleksandr Ivanovych Shevchenko · Biotechnology Journal · 2026

Transdermal Liposomal Delivery Systems: Advantages, Applications, Challenges, and Prospects

Hui Xing, Ziyi Zhao, Xiaoxu Zhu · MedComm – Biomaterials and Applications · 2025

Transferosome Based Delivery of Phytoconstituents in Superficial Fungal Infections: A Comprehensive Review

Jaydeep Jagannath Chemate, Pravin Shridhar Wakte, Sachin Shivling Bhusari · Journal of Drug Delivery and Therapeutics · 2026

Revolutionizing Brain Drug Delivery: Buccal Transferosomes on the Verge of a Breakthrough

Pavuluri Chandrasekhar, Rajaganapathy Kaliyaperumal · Recent Advances in Drug Delivery and Formulation · 2024

A Comprehensive Review on Polyphenols based Nanovesicular System for Topical Delivery

Anshu Singh, Zeeshan Fatima, Dipti Srivastava · Current Drug Delivery · 2025

Showing 13 of 16 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

16

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.